GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Issuance of Debt

Oncodesign Precision Medicine (XPAR:ALOPM) Issuance of Debt : €0.00 Mil (TTM As of Jun. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Issuance of Debt?

Oncodesign Precision Medicine's Issuance of Debt for the six months ended in Jun. 2022 was €0.00 Mil.

Oncodesign Precision Medicine's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2022 was €0.00 Mil.


Oncodesign Precision Medicine Issuance of Debt Historical Data

The historical data trend for Oncodesign Precision Medicine's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Issuance of Debt Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Issuance of Debt
- -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Issuance of Debt - - -

Oncodesign Precision Medicine Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncodesign Precision Medicine Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines